Novartis AG is 185.6x more valuable than Sarepta Therapeutics, Inc. by market capitalization ($293.70 B vs $1.58 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SRPT | NVS |
|---|---|---|
| Market cap | $1.58 B | $293.70 B |
| US-listed rank | #2292 | #46 |
| Revenue (latest FY) | $2.20B | - |
| Net income (latest FY) | -$713.41M | - |
| Net margin | -32.5% | - |
| SEC filings | 1,504 | 947 |
Novartis AG is 185.6x more valuable than Sarepta Therapeutics, Inc. by market capitalization ($293.70 B vs $1.58 B).
Full pages: Sarepta Therapeutics, Inc. and Novartis AG, or browse the full rankings.